Pharma & Bio
Lifestyle
INFINITT Healthcare Rises on 65.4 Billion Won Dividend… SAMIK PHARM. Co., LTD. in the Spotlight [Bio Spotlight]
On the 14th, in the pharmaceutical and biotech sector, INFINITT Healthcare(071200)shares soared to the daily price limit following news that the company would pay a cash dividend totaling 65.4 billion…
- 2026-09-16 08:31:02
- Kim Jinsoo
Technology
Humic, a Leader in Humanized Mice, Now Incorporates Toxicity… H&H Bio’s Transformation
Humic, a company specializing in efficacy evaluations using humanized mouse models, has expanded its business scope to include toxicity testing through a merger with H&H Bio, a non-clinical contract r…
- 2026-09-16 08:06:02
- NA EUN-KYUNG
Technology
Even Bill Gates Has Bet 44.6 Billion; What Lies Ahead for LGCHEM,LTD’s “Hexavalent Vaccine,” Now in Its Ninth Year of Development?
LGCHEM,LTD(051910) The research and development schedule for the “hexavalent combination vaccine” intended for supply to developing countries has been delayed yet again. Following the initial pushback…
- 2026-09-16 07:46:02
- KIM SUNG-JIN
Technology
ABL Bio Inc. Raided Over '1 Billion Won Insider Trading Allegations'—The Key Question Is: Who Knew?
Attention is focusing on the scope of the case as executives and employees of ABL Bio Inc.(298380)(ABL Bio) are undergoing a compulsory investigation on suspicion of purchasing shares after gaining ad…
- 2026-09-15 15:46:02
- NA EUN-KYUNG
Technology
[Report] “Developing New Formulations with 40 Years of Expertise”… RPbio Inc. Sets Its Sights on Overseas Markets
“As a general rule, RPbio Inc.’s soft capsule production process requires that the prepared contents and coating be molded within 72 hours to maintain optimal quality. Typically, once the contents are…
- 2026-09-15 08:42:02
- KIM SUNG-JIN
Technology
KM Pharmaceutical Surges Despite Delisting; SK Biopharm Falls on FDA Hold [K-Bio Pulse]
Korean pharmaceutical and biotech stocks posted mixed results on September 11, with KM Pharmaceutical and BL Pharmtech both hitting their daily upper price limits. KM Pharmaceutical, in particular, su…
- 2026-09-15 08:28:03
- KIM SUNG-JIN
Technology
KMPHARMACEUTICAL Co.,Ltd. Rises on ‘Delisting Notice’… SK BIOPHARMACEUTICALS Falls as FDA Puts Decision on Hold [Bio Spotlight]
On the 11th, the pharmaceutical and biotech sector showed strength, with both KMPHARMACEUTICAL Co.,Ltd.(225430)and BL Pharmtech(065170)hitting their daily price limits. Notably, KMPHARMACEUTICAL Co.,L…
- 2026-09-15 08:28:02
- KIM SUNG-JIN
Technology
“Chinese Biotech Firms Follow South Korean Disclosure Practices”… How K-Bio Can Survive Caught Between the U.S. and China [K-Bio Deal Summit]
Lee Seung-kyu, Vice Chairman of the Korea Bio Association; Heo Hye-min, an analyst at Kiwoom Securities; Han Jeong-hyun, Head of BD&L at Boehringer Ingelheim Korea; and Kim Myung-ki, CEO of LSK Invest…
- 2026-09-15 08:02:02
- KIM SAE-MI
Technology
Coreline Soft Co., Ltd., After Six Years of Dedication… Begins Full-Scale Market Push in Japan with Its Own AI for Detecting Lung Nodules
Coreline Soft Co., Ltd.(384470)has secured approval for the manufacture and sale in Japan of its proprietary artificial intelligence (AI) system for detecting pulmonary nodules, following 5 years and …
- 2026-09-14 11:01:02
- NA EUN-KYUNG
Technology
DongBang Medical Co., Ltd. Enters the Toxin Business... Considering Equity Investment in a Strain-Developing Company
Medical device specialist #DongBang Medical Co., Ltd. is considering entering the botulinum toxin business. Having grown by specializing in dermal fillers, cannulas, and various traditional Korean med…
- 2026-09-14 08:21:02
- KIM SUNG-JIN
PHARM EDAILY
Shorts